CN205612515U - Be used for hemostatic device in uterus - Google Patents

Be used for hemostatic device in uterus Download PDF

Info

Publication number
CN205612515U
CN205612515U CN201620317554.9U CN201620317554U CN205612515U CN 205612515 U CN205612515 U CN 205612515U CN 201620317554 U CN201620317554 U CN 201620317554U CN 205612515 U CN205612515 U CN 205612515U
Authority
CN
China
Prior art keywords
sacculus
uterus
catheterization body
hemostasis
model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201620317554.9U
Other languages
Chinese (zh)
Inventor
吴德印
任兴业
宿世玉
潘雨露
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201620317554.9U priority Critical patent/CN205612515U/en
Application granted granted Critical
Publication of CN205612515U publication Critical patent/CN205612515U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Surgical Instruments (AREA)

Abstract

The utility model provides a be used for hemostatic device in uterus, it has the catheterization body, and catheterization body one side is equipped with the intake pipe, and the intake pipe other end has the venthole, and catheterization body front end system has the thickening sacculus, and at the hob of the external side of catheter cover case ring shape sprue, near the fixed dog of intake pipe department's installation, it has the swivel nut of taking the handle to overlap on the fixed dog, screw in the swivel nut is corresponding with the screw on the hob, and catheterization body front end is equipped with first through -hole and second through -hole. The utility model discloses in mainly being used in the case that the early pregnancy stream of people of uterus scar department bled, can solve the fixed difficult problem of current catheter lower extreme, can adjust fixedly simultaneously according to patient's cervical length, make the sacculus of palace intracavity hug closely palace chamber wall, reduce the uterus dead space to according to how many adjusted spiral poles of amount of bleeding or drawing liquid decompression, the oppression hemostatic effect showing, and it is normally movable not influence patient.

Description

Device for uterine hemostasis
Technical field
This utility model relates to medical equipment, is a kind of device for uterine hemostasis.
Background technology
In medicinal, at Uterine Scar, early pregnancy abortion is gynecological's operation most common, most widely used, Uterine cavity is hemorrhage is also frequently problem in this kind of operation, uses cavity of uterus to place double lumen catheter as drain Pipe, balloon compression hemostasis is the method commonly used clinically.According to uterine cavity size and Compressive Hemostasis by sacculus water filling 20~40ml hemostasiss by compression, another termination drainage bag of sacculus observes blood volume.The published patent No. 201320019215, the structure of title uterine hemostasis sacculus is: in being placed in liquid sacculus in double channel catheter one end, Inject saline in sacculus is inserted cavity of uterus, make sacculus expansion be affixed on uterus inwall and play hemostasis by compression effect;But Clinical practice process there is the problem that the fixing difficulty in double channel catheter outer end, and sacculus is expanded after placing in uterine cavity fluid injection again, An outside pulling force tractive catheter is needed to keep some tension.In clinic through frequently with wide adhesive plaster by leading after drop-down Pipe end is fixed on inside patient thigh or binding normal saline bottle produces pulling force, makes sacculus only be close to uterus compressing Blood, there is the problem that and easily affected by patient activity or position, does not reaches the certain pulling force of holding and makes sacculus fixed Position realizes the effect of uterus hemostasis by compression in bleeding part, and the position both having limited patient is movable, affects again hemostasis by compression Effect.
Utility model content
The purpose of this utility model provides a kind of device for uterine hemostasis, is used primarily at Uterine Scar the most pregnant In the case that the artificial abortion that is pregnent is hemorrhage, it is possible to solve the fixing difficult problem in existing catheter lower end, simultaneously can be according to patient palace Neck length degree is adjusted fixing, and makes intrauterine sacculus be close to uterine cavity wall, reduces uterus dead space, and according to amount of bleeding How many adjustment screw rods or drawing liquid decompression, Compressive Hemostasis is notable, does not affect patient's normal activity.
The purpose of this utility model is achieved through the following technical solutions: of the present utility model for uterine hemostasis Device, it has urethral catheterization body, urethral catheterization body side to be provided with air inlet pipe, and the air inlet pipe other end has venthole, catheter Body front end is shaped with thickening sacculus, at the screw rod of catheter external side suit band annular sprue, at air inlet pipe Fixed stop is installed, fixed stop is cased with the swivel nut of band handle, the screw thread in described swivel nut and the spiral shell on screw rod Stricture of vagina is corresponding, and urethral catheterization body front end is provided with the first through hole and the second through hole.Fixed stop is ring-type fluted shape.Circle Annular sprue is that duroplasts is made.Annular sprue is connected for fixing with screw rod.Thicken a diameter of 3-6 of sacculus Centimetre.
This utility model has the beneficial effects that: transformed by catheter sacculus to uterine hemostasis in clinic, solves The fixing difficult problem in catheter lower end, can be adjusted sacculus according to patient cervical length by screw rod simultaneously and consolidate Location is put, and in making uterine cavity, sacculus is close to uterine cavity wall, reduces uterus dead space, and Compressive Hemostasis is notable, does not affect disease People's normal activity.And adjust screw rod pulling force or drawing liquid decompression according to amount of bleeding, when 24~48 is little, vagina is without hemorrhage This utility model hemostasis device can be extracted, be truly realized the using effect that can be suitable for all ages and classes patient, can be wide General popularization and application.
Typical case falls ill: the case that at Uterine Scar, early pregnancy artificial abortion is hemorrhage, by using this utility model in utero ball Capsule hemostasis device hemostasis by compression achieves preferable curative effect, and model case is as follows:
Example 1, patient 36 years old, pregnant 2 produce 1, cesarean postoperate 2 years.Menolipsis 48 days, vagina is over the most hemorrhage 3 days Examine.B ultrasonic: in cavity of uterus, nearly hypomere antetheca is visited and the low echo area of 1.2cm × 1.0cm, inside sees yolk sac.Blood β -HCG 11630.00U/L.Patient requests's termination of pregnancy, gives artificial abortion in outpatient service, and operation smoothly, is shown in fine hair And decidua tissue, but postoperative hemorrhage is many, gives intramuscular injection Leonurus Heterophyllus injection and slightly reduces and go home.Patient the 2nd day is hemorrhage The most more check, B ultrasonic: see uterine cavity antetheca irregular agglomerate echo, be diagnosed as gestation at the cicatrix of uterus, take in institute I.e. give cavity of uterus and place this utility model in utero sacculus hemostasis device, in sacculus water filling 40ml hemostasis by compression, multiple Look into liver function normal, give methotrexate 20mg intramuscular injection qd, totally 5 times, mifepristone 50mg, every 12h 1 time, even Taking 5d, after this utility model in utero sacculus hemostasis device indwelling 2d, vagina is fully recovered after hemorrhage, extracts this practicality new Type hemostasis device.
Example 2, patient 30 years old, pregnant 3 produce 1, cesarean postoperate 9 years.Because of menolipsis 48 days, in little outpatient service from taking miscarriage Within after medicine 3 days, having no that tissue substance is discharged but hemorrhage examined more, transvaginal ultrasound shows: have no pregnant capsule, uterus in uterine cavity Antetheca hypomere has the low echo enclosed mass of about 3 0cm × 3 2cm, blood HCG 7865U/L.It is diagnosed as uterus Gestation at cicatrix, outpatient service is hemorrhage more, at once with oval when giving row uterine curettage with " imperfection drug induced abortion " Ward is taken in after pincers clamp cervix uteri.First employing Metotrexate Combined with Mifepristone Drug therapy: MTX20mg intramuscular injection qd, Totally 5 times, and oral mifepristone 50mg, every 12h 1 time, it serve on 5d, give antibacterials prevention simultaneously and infect. Monitoring β-HCG gives the clearing heat in the pericardium, all to bleed profusely in art after dropping to 1000U/L, and the clearing heat in the pericardium is complete the most immediately at uterine cavity Interior placement this utility model in utero sacculus hemostasis device, according to uterine cavity size and Compressive Hemostasis in sacculus water filling 20~40ml hemostasiss by compression, observe without obvious hemorrhage rear fixing screw rod, this utility model in utero sacculus hemostasis device End connects drainage bag and observes blood volume.And adjust screw rod according to haemostatic effect 4~10h.And often 12h is the most every Haemostatic effect is observed in secondary drawing liquid 10ml decompression, and 24~48h vaginas are fully recovered after hemorrhage, extracts this utility model hemostasis Device.
Example 3, patient 26 years old, pregnant 2 produce 1, cesarean postoperate 3.Because of menolipsis 42 days, vagina was over dripping hemorrhage 3 days Examine.Gynecologial examination: intravaginal courageous and upright secretions on a small quantity, cervix uteri is smooth, normal in size, anteversion of uterus, and pregnant 40 days big Little, lower uterine segment expands, and matter is soft, and without tenderness, double accessory is normal.Vagina supersonic inspection shows palace body 4.3cm × 4.0cm × 3.8cm, cervix uteri nearly internal orifice uterus visible 1.2cmx1.4cm heterogeneous echopattern agglomerate to the front, make a definite diagnosis uterine incision At cicatrix, early pregnancy admits to hospital.First employing Metotrexate Combined with Mifepristone Drug therapy: MTX20mg intramuscular injection qd, Totally 5 times, and oral mifepristone 50mg, every 12h 1 time, it serve on 5d, give antibacterials prevention simultaneously and infect. Monitoring β-HCG gives the clearing heat in the pericardium, all to bleed profusely in art after dropping to 1000U/L, and the clearing heat in the pericardium is complete the most immediately at uterine cavity Interior placement this utility model in utero sacculus hemostasis device, according to uterine cavity size and Compressive Hemostasis in sacculus water filling 20~40ml hemostasiss by compression, observe without obvious hemorrhage rear fixing screw rod, this utility model in utero sacculus hemostasis device End connects drainage bag and observes blood volume.And adjust screw rod according to haemostatic effect 4~10h.And often 12h is the most every Haemostatic effect is observed in secondary drawing liquid 10ml decompression, and 24~48h vaginas are fully recovered after hemorrhage, extracts this utility model hemostasis Device.
Example 4, patient, female, 23, pregnant 1 produces 1, cesarean postoperate 1 year half, and because of menolipsis 45 days, vagina bled 1 on a small quantity It is gone to a doctor.Uterus normal in size is shown in ultrasound diagnosis, 0.9cmx1 2cm seen from lower uterine segment antetheca incisional scar × 1.3cm heterogeneous echopattern district.Make a definite diagnosis uterine incision cicatrix position gestation to admit to hospital.First use methotrexate associating rice Mifepristone Drug therapy: MTX20mg intramuscular injection qd, totally 5 times, and oral mifepristone 50mg, every 12h 1 time, even Take 5d, give antibacterials prevention simultaneously and infect.Monitoring β-HCG gives the clearing heat in the pericardium, art after dropping to 1000U/L In all bleed profusely, the clearing heat in the pericardium is complete places this utility model in utero sacculus hemostasis device, and root the most immediately in uterine cavity According to uterine cavity size and Compressive Hemostasis in sacculus water filling 20~40ml hemostasis by compression, observe without obvious hemorrhage after solid Determining screw rod, this utility model in utero sacculus hemostasis device end connects drainage bag and observes blood volume.And according to hemostasis effect Really 4~10h adjust screw rod.And every 12h gradually every time drawing liquid 10ml decompression observe haemostatic effect, 24~48h Vagina is fully recovered after hemorrhage, extracts this utility model hemostasis device.
The patient of above model case all apply in utero sacculus local pressing type hemostasia and control hemorrhage, saved uterus from damage And make patient from the hardship operated on.Postoperative without infecting, without palace wall and cervix uteri pressurized ischemic necrosis, menstruation recovery, by This proves that sacculus indwelling time and pressure, in safety range, do not cause complication, can in basic unit clinical, special or The popularization and application of condition name without Emergent intervention.
Accompanying drawing explanation
Fig. 1 is structural representation of the present utility model.Fig. 2 is the structural representation of screw rod 5 in Fig. 1.Fig. 3 Right TV structure schematic diagram for Fig. 2.
Detailed description of the invention
Device for uterine hemostasis of the present utility model, it have urethral catheterization body 1, urethral catheterization body 1 side be provided with into Trachea 12, air inlet pipe 12 other end has venthole 10, urethral catheterization body 1 front end to be shaped with thickening sacculus 7, in urethral catheterization It is set with the screw rod 5 of band annular sprue 6 outside body 1, fixed stop 2 is installed at air inlet pipe 12, Gu Determine to be cased with on block 2 swivel nut 4 of band handle 3, the screw thread 11 in described swivel nut 4 and the screw thread phase on screw rod 5 Correspondence, urethral catheterization body 1 front end is provided with the first through hole 8 and the second through hole 9.Described fixed stop 2 is ring-type slot type Shape, annular sprue 6 is made for duroplasts.Make swivel nut 4 can in slot type fixed stop 2 rotary moveable.Institute State annular sprue 6 to be connected for fixing with screw rod 5.This structural strengthening annular sprue 6 and screw rod 5 Stability.A diameter of 3-6 centimetre of described thickening sacculus 7, it is capable of the high pressure of sacculus 7, Gao Rongji The purpose of high-tension.
When this utility model is installed, fixed stop 2 is fixed on urethral catheterization body 1 upper surface, and annular hand grip 3 is stuck in solid Determining in the cannelure of block 2, the screw thread 11 in swivel nut 4 is meshed with the screw thread on screw rod 5, passes through air inlet Pipe 12 makes gas enter in sacculus 7.During use, gas is made to enter sacculus 7, and on request by air inlet pipe 12 Inject quantitative liquid, make to be close to the sacculus 7 of expansion of liquids on hemorrhage uterine cavity wall, then turning handle 3 Promote screw rod 5 to move ahead, make the annular sprue 6 on screw rod 5 be adjacent to vaginal orifice outer wall, play fixing ball The effect of capsule 7 realizes hemostasis purpose.Described urethral catheterization body 1 front end be provided with the first through hole 8 and the second through hole 9 for Drawing palace intracavity blood, described urethral catheterization body 1 is known technology.The non-detailed description of this utility model is known technology.

Claims (5)

1., for the device of uterine hemostasis, it has urethral catheterization body (1), urethral catheterization body (1) side to be provided with air inlet pipe (12), air inlet pipe (12) other end has venthole (10), it is characterised in that: urethral catheterization body (1) front end system There is thickening sacculus (7), at the screw rod (5) of urethral catheterization body (1) outside suit band annular sprue (6), lean on Fixed stop (2) is installed at nearly air inlet pipe (12) place, and fixed stop (2) is cased with the swivel nut (4) of band handle (3), Screw thread (11) in described swivel nut (4) is corresponding with the screw thread on screw rod (5), and urethral catheterization body (1) is front End is provided with the first through hole (8) and the second through hole (9).
Device for uterine hemostasis the most according to claim 1, it is characterised in that: fixed stop (2) For ring-type fluted shape.
Device for uterine hemostasis the most according to claim 1, it is characterised in that: annular sprue (6) Make for duroplasts.
Device for uterine hemostasis the most according to claim 1, it is characterised in that: annular sprue (6) It is connected for fixing with screw rod (5).
Device for uterine hemostasis the most according to claim 1, it is characterised in that: thicken sacculus (7) A diameter of 3-6 centimetre.
CN201620317554.9U 2016-04-14 2016-04-14 Be used for hemostatic device in uterus Expired - Fee Related CN205612515U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201620317554.9U CN205612515U (en) 2016-04-14 2016-04-14 Be used for hemostatic device in uterus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201620317554.9U CN205612515U (en) 2016-04-14 2016-04-14 Be used for hemostatic device in uterus

Publications (1)

Publication Number Publication Date
CN205612515U true CN205612515U (en) 2016-10-05

Family

ID=57030541

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201620317554.9U Expired - Fee Related CN205612515U (en) 2016-04-14 2016-04-14 Be used for hemostatic device in uterus

Country Status (1)

Country Link
CN (1) CN205612515U (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105708514A (en) * 2016-04-14 2016-06-29 吴德印 Device for uterus hemostasis
WO2019105519A1 (en) * 2017-12-03 2019-06-06 Abd Elaal Nasser Kamal Tranexamic acid coated or eluted uterine balloon and co-attached cervical shutter in the management of postpartum haemorrhage
CN110680442A (en) * 2019-10-16 2020-01-14 张玲 A sacculus system for postpartum recovery
CN111388047A (en) * 2020-03-27 2020-07-10 杭州市第一人民医院 Uterine cavity hemostasis assembly for postpartum puerpera

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105708514A (en) * 2016-04-14 2016-06-29 吴德印 Device for uterus hemostasis
WO2019105519A1 (en) * 2017-12-03 2019-06-06 Abd Elaal Nasser Kamal Tranexamic acid coated or eluted uterine balloon and co-attached cervical shutter in the management of postpartum haemorrhage
US11717325B2 (en) 2017-12-03 2023-08-08 Nasser Kamal Abd Elaal Medicated uterine balloon with cervical barricade for management of postpartum hemorrhage
CN110680442A (en) * 2019-10-16 2020-01-14 张玲 A sacculus system for postpartum recovery
CN110680442B (en) * 2019-10-16 2020-10-27 张玲 A sacculus system for postpartum recovery
CN111388047A (en) * 2020-03-27 2020-07-10 杭州市第一人民医院 Uterine cavity hemostasis assembly for postpartum puerpera

Similar Documents

Publication Publication Date Title
CN105708514A (en) Device for uterus hemostasis
CN205612515U (en) Be used for hemostatic device in uterus
CN202776442U (en) Packing device for treating uterine bleeding
CN107670166A (en) Three chamber uterine neck balloon dilatation catheters
CN202637025U (en) Sacculus uterine support
CN205494630U (en) Prevent sacculus uterus support of oppression
CN109513097A (en) A kind of two-tube balloon-stent for preventing and treating Asherman's syndrom
CN203290958U (en) Three-cavity water sac used for hemostasis by compression in early pregnant uterus cavity
CN203468711U (en) Multifunctional intrauterine adhesion control and treatment unit
CN101541256A (en) Apparatus for collecting the amniotic fluid from the uterus
CN110559061A (en) anti-adhesion tension-free uterine cavity conformable barrier and using method thereof
CN206508369U (en) One uterine cryptomere support tube
Peng et al. Exploration of the successful treatment algorithms used in 23 cases of early live cesarean scar pregnancy
CN203139357U (en) Gynecological triple-bag multi-cavity tube
CN202859206U (en) Carrier barrier system applied to prevention and treatment of intrauterine adhesion
CN203724193U (en) Amniotic membrane pushing-in device for cerclage
CN203971144U (en) Salpingography recanalization conduit
CN203329172U (en) Device for preventing and treating intrauterine adhesion and cervical adhesion
CN206434397U (en) A kind of uterus and uterine neck hemostasis sacculus
CN201692487U (en) Double-sac cervix expanding duct
Quinlan Researches into sterility of cows in South Africa
CN208081646U (en) Three chamber uterine neck balloon dilatation catheters
CN208974055U (en) Disposable improvement induction of labor with water bag device
CN209575501U (en) The anti-multi-functional dressing of HPV beta glucan
CN103055408A (en) Gynaecology three-balloon multi-cavity catheter

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20161005

Termination date: 20190414

CF01 Termination of patent right due to non-payment of annual fee